United Therapeutics UTHR
NASDAQ UTHR
$595.66 +7.05 (+1.20%)
At close: Nov 11, 2026 · 4:00 PM EST

United Therapeutics (UTHR) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

United Therapeutics' Return on Capital Employed [ROCE] was 22.04% in Q2 2026, up 2.20 percentage points from 19.84% a year earlier and up 0.61 percentage points from the prior quarter.

Analysis

United Therapeutics (UTHR) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at United Therapeutics came in at 21.14%, up 0.04 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has now increased for four consecutive years, with a five-year change of +6.07 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was 21.10% in FY2024 (+0.67 pp), 20.42% in FY2023 (+1.81 pp), 18.61% in FY2022 (+6.49 pp) and 12.12% in FY2021 (-2.94 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] since Q4 2018.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in four of the last eight quarters, with an average year-over-year change of +0.74 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2022 (a gain of 9.91 percentage points); the worst was Q3 2021 (a drop of 4.83 percentage points).
  • Per Business Quant data, UTHR's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was 21.43% (Q1 2026), 21.16% (Q4 2025) and 21.08% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 United Therapeutics 24.95 Bn 15.14 Bn 733.40 Mn 20.32%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 20.32%
Jun 30, 2026 22.04%
Mar 31, 2026 21.43%
Dec 31, 2025 21.16%
Sep 30, 2025 21.08%
Jun 30, 2025 19.84%
Mar 31, 2025 20.54%
Dec 31, 2024 21.17%
Sep 30, 2024 21.15%
Jun 30, 2024 21.87%
Mar 31, 2024 21.05%
Dec 31, 2023 18.84%
Sep 30, 2023 18.01%
Jun 30, 2023 17.71%
Mar 31, 2023 16.63%
Dec 31, 2022 17.59%
Sep 30, 2022 18.22%
Jun 30, 2022 17.35%
Mar 31, 2022 18.28%
Dec 31, 2021 11.57%
API Access

United Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=UTHR&period=max&api_key=YOUR_API_KEY